Cypress Capital, LLC Evogene Ltd. Transaction History
Cypress Capital, LLC
- $334 Million
- Q2 2024
A detailed history of Cypress Capital, LLC transactions in Evogene Ltd. stock. As of the latest transaction made, Cypress Capital, LLC holds 400 shares of EVGN stock, worth $1,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400Holding current value
$1,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EVGN
# of Institutions
30Shares Held
3.94MCall Options Held
400Put Options Held
0-
Silverarc Capital Management, LLC3.08MShares$7.7 Million0.57% of portfolio
-
Morgan Stanley New York, NY218KShares$546,1370.0% of portfolio
-
Eidelman Virant Capital117KShares$292,5000.07% of portfolio
-
Lpl Financial LLC Fort Mill, SC67.3KShares$168,3370.0% of portfolio
-
Ubs Group Ag66KShares$165,0120.0% of portfolio
About Evogene Ltd.
- Ticker EVGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,202,000
- Market Cap $103M
- Description
- Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...